# Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

> **NCT01669434** · PHASE4 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 291 (actual)

## Conditions studied

- Hypotension on Induction

## Interventions

- **DRUG:** ACEI continuation
- **DRUG:** ACEI omission

## Key facts

- **NCT ID:** NCT01669434
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-01
- **Primary completion:** 2016-11-01
- **Final completion:** 2016-12-01
- **Target enrollment:** 291 (ACTUAL)
- **Last updated:** 2023-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01669434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01669434, "Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01669434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*